EVALUATING PROLACTIN RESPONSE TO DOPAMINE AGONISTS IN SCHIZOPHRENIA - METHODOLOGICAL PROBLEMS

被引：0
|
作者：
DAVIS, BM
DAVIS, KL
MOHS, RC
MATHE, AA
ROTHPEARL, AB
JOHNS, CA
LEVY, MI
HORVATH, TB
机构：
[1] VET ADM MED CTR,BRONX,NY 10468
[2] CUNY MT SINAI SCH MED,NEW YORK,NY 10029
来源：
ARCHIVES OF GENERAL PSYCHIATRY | 1985年 / 42卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：259 / 264
页数：6
相关论文
共 50 条
  • [1] Prolactin, prolactin disorders, and dopamine agonists during pregnancy
    Gabriel Levin
    Amihai Rottenstreich
    Hormones, 2019, 18 : 137 - 139
  • [2] Prolactin, prolactin disorders, and dopamine agonists during pregnancy
    Levin, Gabriel
    Rottenstreich, Amihai
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 18 (02): : 137 - 139
  • [3] DOPAMINE AGONISTS IN THE TREATMENT OF SCHIZOPHRENIA
    DELZOMPO, M
    BOCCHETTA, A
    PICCARDI, MP
    CORSINI, GU
    PROGRESS IN BRAIN RESEARCH, 1986, 65 : 41 - 48
  • [4] Dopamine agonists in schizophrenia: A review
    Benkert, O
    MullerSiecheneder, F
    Wetzel, H
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1995, 5 : 43 - 53
  • [5] Partial dopamine agonists in schizophrenia
    Launer, M
    HOSPITAL MEDICINE, 2005, 66 (05): : 300 - 303
  • [6] SUPPRESSION OF PROLACTIN BY DOPAMINE AGONISTS IN SCHIZOPHRENICS AND CONTROLS
    ROTROSEN, J
    ANGRIST, B
    CLARK, C
    GERSHON, S
    HALPERN, FS
    SACHAR, EJ
    AMERICAN JOURNAL OF PSYCHIATRY, 1978, 135 (08): : 949 - 951
  • [7] THE USE OF DOPAMINE AGONISTS IN THE TREATMENT OF SCHIZOPHRENIA
    CORSINI, GU
    PITZALIS, GF
    BERNARDI, F
    BOCCHETTA, A
    DELZOMPO, M
    NEUROPHARMACOLOGY, 1981, 20 (12B) : 1309 - 1313
  • [8] DOPAMINE AGONISTS FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
    KING, DJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (06) : 541 - 542
  • [9] Metabolic effects of prolactin and the role of dopamine agonists: A review
    Kirsch, Polly
    Kunadia, Jessica
    Shah, Shruti
    Agrawal, Nidhi
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Dopamine partial agonists as an approach for treating schizophrenia
    Eriksson, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S406 - S406
12345